Filter on category

Downloads

filter

Nyxoah Q1 2023 report

16 May 2023

Financial

Download (ENG) Download (FR)

Special auditor report - Articles 7:198 juncto 7:179, 7:191 and 7:193 CCA (Private placement)

30 March 2023

Special Reports

Special board report - Articles 7:198 juncto 7:179, 7:191 and 7:193 CCA (Private placement)

30 March 2023

Special Reports

Download (ENG) Download (FR)

Nyxoah Annual Report 2022

22 March 2023

Financial

Download (ENG PDF) Download (FR ESEF) Download (FR PDF) Download (FR ESEF zip)

Nyxoah Q1 2022 report

10 May 2022

Financial

Download (ENG) Download (FR)

Nyxoah Annual Report 2021

24 March 2022

Financial

Download (ENG PDF) Download (FR ESEF) Download (FR PDF) Download (FR ESEP zip)

Special board report – Articles 7:179, 7:191 and 7:193 CCA (Nasdaq IPO)

25 June 2021

Special Reports

Download (ENG) Download (FR)

Special auditor report – Articles 7:179, 7:191 and 7:193 CCA (Nasdaq IPO)

25 June 2021

Special Reports

Nyxoah Q1 Report 2021

10 June 2021

Financial

Nyxoah Annual report 2020

9 April 2021

Financial

Download (ENG) Download (FR)

All rights reserved © 2021 Nyxoah SA. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah SA. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio^® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020

Cookie Settings